OCM
AMGN icon

Osbon Capital Management’s Amgen AMGN Stock Holding History

Osbon Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Buy
3,344
+2,000
+149% +$713K 0.96% 19
2025
Q4 		$440K Buy
+1,344
New +$426K 0.41% 38
2019
Q2 		$285K Buy
+1,547
New +$277K 0.3% 42

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Osbon Capital Management's AMGN Position: Q1 2026 in Review

Osbon Capital Management increased its Amgen (AMGN) stake by 149% in Q1 2026, buying an estimated $713K and bringing the position to 3,344 shares worth $1.18M. The position accounts for 0.96% of the portfolio, ranked #19.

Osbon Capital Management first reported a position in AMGN in Q2 2019 and has held it in 3 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Osbon Capital Management held 3,344 shares of Amgen worth $1.18M as of Q1 2026.
  • Osbon Capital Management bought 2,000 Amgen shares in Q1 2026, an estimated $713K.
  • Amgen made up 0.96% of Osbon Capital Management's portfolio in Q1 2026, its #19 holding.
  • Osbon Capital Management first reported a position in Amgen in Q2 2019 and has held it in 3 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Osbon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.